King Pharmaceuticals Announces FDA Approval of Epistaxis Kit for THROMBIN-JMI(R).
Permanent Link:
http://vlex.com/vid/king-fda-epistaxis-kit-thrombin-jmi-55924914
Id. vLex: VLEX-55924914
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
King Pharmaceuticals Announces FDA Approval of Epistaxis Kit for THROMBIN-JMI(R).
BRISTOL, Tenn. -- King Pharmaceuticals, Inc. (NYSE:KG) announced today the U.S. Food and Drug Administration (FDA) approval of the Company's THROMBIN-JMI([R])Epistaxis Kit, a new intranasal spray delivery device for THROMBIN-JMI([R]) (thrombin, topical, bovine, USP) for use to aid in stopping epi...
Try vLex for FREE for 3 days
Access legal information from United States including:
- Constitutions
- Forms and Contracts
- Legal Books and Journals
- Case Law
- News and Business
- Regulations
- U.S. Code
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here
